What Codiak BioSciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Howze Yalonda | See Remarks | Mar 30 | Open-market sale · S | −1,628 | $0.20 | −$318 | 7,458 |
| Barna Nicole | See Remarks | Mar 29 | Open-market sale · S | −1,932 | $0.17 | −$321 | 4,849 |
| Barna Nicole | See Remarks | Mar 29 | Open-market sale · S | −5,373 | $0.17 | −$887 | 6,781 |
| Sathyanarayanan Sriram | Chief Scientific Officer | Mar 29 | Open-market sale · S | −11,762 | $0.17 | −$1.94K | 0 |
| Bain Linda | Chief Financial Officer | Mar 28 | Open-market sale · S | −13,412 | $0.17 | −$2.27K | 0 |
| Williams Douglas E | President & CEO | Mar 28 | Open-market sale · S | −41,667 | $0.18 | −$7.5K | 7,655 |
| Konstantinov Konstantin | Chief Technology Officer | Mar 28 | Open-market sale · S | −1,932 | $0.20 | −$386 | 0 |
| Konstantinov Konstantin | Chief Technology Officer | Mar 28 | Open-market sale · S | −7,432 | $0.20 | −$1.49K | 1,932 |
| Bain Linda | Chief Financial Officer | Feb 17 | Open-market sale · S | −2,570 | $0.59 | −$1.52K | 13,412 |
| Howze Yalonda | See Remarks | Feb 17 | Open-market sale · S | −1,603 | $0.59 | −$950 | 9,086 |
| Sathyanarayanan Sriram | Chief Scientific Officer | Feb 17 | Open-market sale · S | −2,407 | $0.59 | −$1.43K | 11,762 |
| Barna Nicole | See Remarks | Feb 17 | Open-market sale · S | −1,274 | $0.59 | −$755 | 12,154 |
| Williams Douglas E | President & CEO | Feb 17 | Open-market sale · S | −7,681 | $0.59 | −$4.55K | 49,322 |
| Konstantinov Konstantin | Chief Technology Officer | Feb 17 | Open-market sale · S | −1,391 | $0.59 | −$824 | 7,432 |
| Bain Linda | Chief Financial Officer | Feb 16 | Exercise / conversion · M | +7,613 | — | — | 15,982 |
| Gillis Steven | Director | Feb 16 | Exercise / conversion · M | +8,750 | — | — | 8,750 |
| Howze Yalonda | See Remarks | Feb 16 | Exercise / conversion · M | +4,856 | — | — | 10,689 |
| Melas Kyriazi Theo | Director | Feb 16 | Exercise / conversion · M | +8,750 | — | — | 15,350 |
| Bernstein Karen | Director | Feb 16 | Exercise / conversion · M | +8,750 | — | — | 8,750 |
| Haddock Jason | Director | Feb 16 | Exercise / conversion · M | +8,750 | — | — | 8,750 |
Loading...